Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maria Yannaraki"'
Autor:
Jamal Bamoulid, Hélène Philippot, Amir Kazory, Maria Yannaraki, Thomas Crepin, Bérengère Vivet, Nadège Devillard, Caroline Roubiou, Catherine Bresson-Vautrin, Jean-Marc Chalopin, Cécile Courivaud, Didier Ducloux
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Acute kidney injury (AKI) is still characterized by a high mortality rate. While most patients with AKI are admitted in conventional medical units, current available data are still obtained from studies designed for patients admit
Externí odkaz:
https://doaj.org/article/19dd226bd6a1495b97bedb580b802b1b
Autor:
Didier DUCLOUX, Jamal BAMOULID, Melchior CHABANNES, Mathilde COLLADANT, Abdulaziz MUNSHI, Caroline ROUBIOU, Jean SEIBEL, Amine TACHIKART, Maria YANNARAKI, Thomas CREPIN, Cécile COURIVAUD
Publikováno v:
Journal of Infection. 84:e34-e35
Publikováno v:
Kidney International
Publikováno v:
Clinical Kidney Journal
Autor:
Thomas Crepin, Jamal Bamoulid, Cécile Courivaud, Didier Ducloux, Jean-Marc Chalopin, Maria Yannaraki, C. Bresson-Vautrin, Nadège Devillard, Bérengère Vivet, Amir Kazory, Hélène Philippot, Caroline Roubiou
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019)
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019)
BackgroundAcute kidney injury (AKI) is still characterized by a high mortality rate. While most patients with AKI are admitted in conventional medical units, current available data are still obtained from studies designed for patients admitted in int
Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection*
Autor:
Sophie Felix, Gérard Rifle, Christophe Ferrand, Jean-Michel Rebibou, Philippe Saas, Jean-Marc Chalopin, Pierre Tiberghien, Maria Yannaraki, Patrick Hervé, Anne Duperrier, Didier Ducloux
Publikováno v:
Transplant International
Transplant International, Wiley, 2006, 19 (9), pp.759-68. ⟨10.1111/j.1432-2277.2006.00351.x⟩
Transplant International, Wiley, 2006, 19 (9), pp.759-68. ⟨10.1111/j.1432-2277.2006.00351.x⟩
International audience; Perforin (P), Granzyme B (GB) and Fas-Ligand (FAS-L) are cytotoxic molecules involved in acute rejection (AR) after renal transplantation. A noninvasive diagnostic test to monitor AR and other complications could improve clini
Autor:
Christine Binquet, Rémi Bruyère, Agnès Soudry-Faure, Abdelouaid Nadji, Gilles Capellier, Saber Barbar, Jean-Pierre Quenot, Maria Yannaraki, Stephane Torner, Gilles Blasco
Publikováno v:
Trials
Background The incidence of acute kidney injury (AKI) is estimated at 10 to 20% in patients admitted to intensive care units (ICU) and often requires renal replacement therapy (RRT). ICU mortality in AKI patients can exceed 50%. Venous catheters are
Autor:
Chantal Thevenin, Pierre Tiberghien, Jean-Michel Rebibou, Maria Yannaraki, Emeline Masson, Jacqueline Chabod, Nadège Devillard
Publikováno v:
Human Immunology
Human Immunology, Elsevier, 2010, 71 (2), pp.170-5. ⟨10.1016/j.humimm.2009.11.003⟩
Human Immunology, Elsevier, 2010, 71 (2), pp.170-5. ⟨10.1016/j.humimm.2009.11.003⟩
International audience; Anti-HLA antibody (Ab) monitoring is essential for the follow-up of transplant patients. However, it can be affected by drugs, especially Ab infused as a conditioning regimen for transplantation. ATG Fresenius, commonly used i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e165be59ffeb07bf35c7efdbf4655dc3
https://www.hal.inserm.fr/inserm-00484267
https://www.hal.inserm.fr/inserm-00484267
Autor:
Véronique Fayol, Nadège Devillard, Gérard Motte, Claude Guy, V. Fournier, Maria Yannaraki, Didier Ducloux, Gilbert Zanetta, Marc Kribs, Amir Kazory, Jean-Marc Chalopin
Publikováno v:
American Journal of Kidney Diseases. 51:B57
Autor:
Christophe Ferrand, Marina Deschamps, Amir Kazory, Pierre Tiberghien, Philippe Saas, Jamal Bamoulid, Didier Ducloux, Jean-Marc Chalopin, Maria Yannaraki
Publikováno v:
Kidney International. (6):2454-2461
Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Background Polymorphisms in Toll-like receptor-4 (TLR4) have been reported to be associated with a blunted immune response to microbial pathogens, as well as a decreased risk o